Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01701037
Title Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center



Dabrafenib + Trametinib


Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 United States Details
*Shaded cells indicate that there was no data available from for the field